Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:cancer
gptkb:Lymphoma |
| gptkbp:affects |
Adults
Immunocompromised individuals |
| gptkbp:alsoKnownAs |
gptkb:Body_cavity–based_lymphoma
|
| gptkbp:associatedVirus |
Epstein-Barr virus (sometimes)
|
| gptkbp:associatedWith |
gptkb:Human_herpesvirus_8
HIV infection Immunosuppression |
| gptkbp:cellOrigin |
gptkb:B_cell
|
| gptkbp:characterizedBy |
Malignant effusions in body cavities
|
| gptkbp:diseaseOf |
Lymphatic system
|
| gptkbp:firstDescribed |
1996
|
| gptkbp:frequency |
Rare
|
| gptkbp:hasImmunophenotype |
CD30 positive
CD138 positive CD20 negative CD45 positive |
| gptkbp:ICD-10_code |
C85.8
|
| gptkbp:mortalityRate |
High
|
| gptkbp:prognosis |
Poor
|
| gptkbp:rarelyForms |
Solid tumor masses
|
| gptkbp:treatment |
Chemotherapy
Antiretroviral therapy |
| gptkbp:website |
gptkb:Pericardial_cavity
gptkb:Pleural_cavity gptkb:Peritoneal_cavity |
| gptkbp:bfsParent |
gptkb:KSHV
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Primary effusion lymphoma
|